arrow
Z

Zhiqiang Ku

university of texas health science center
H指数:32
被引数:6,136

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in KRAS-mutant non–small cell lung cancer

靶向PCDH7的单克隆抗体抑制KRAS突变非小细胞肺癌的生长并增强免疫反应

2026-06-030
OA
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer

Claudins与LILRB免疫抑制受体相互作用,以促进癌症中的髓系免疫抑制。

2026-04-030
PRE
Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

作者更正:IgM的鼻内给药可提供针对SARS-CoV-2变体的广泛保护

Nature
IF48.5
2025-11-270
PRE
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
2023-12-112
OAAI
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L
2023-04-2614
OAAI
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
2022-09-2222
OAAI
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2021-08-1139
OA
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Nature
IF48.5
2021-06-030
PREAI